Ritter G - Search Results

1

Antibody response to immunization with ganglioside GD3 and GD3 congeners (lactones, amide and gangliosidol) in patients with malignant melanoma.

Ritter G, Boosfeld E, Adluri R, Calves M, Oettgen HF, Old LJ, Livingston P. Ritter G, et al. Int J Cancer. 1991 May 30;48(3):379-85. doi: 10.1002/ijc.2910480312. Int J Cancer. 1991. PMID: 2040532

2

Ganglioside antigens expressed by human cancer cells.

Ritter G, Livingston PO. Ritter G, et al. Semin Cancer Biol. 1991 Dec;2(6):401-9. Semin Cancer Biol. 1991. PMID: 1810468 Review.

3

Antibody response to immunization with purified GD3 ganglioside and GD3 derivatives (lactones, amide and gangliosidol) in the mouse.

Ritter G, Boosfeld E, Calves MJ, Oettgen HF, Old LJ, Livingston PO. Ritter G, et al. Immunobiology. 1990 Dec;182(1):32-43. doi: 10.1016/S0171-2985(11)80581-4. Immunobiology. 1990. PMID: 2098322

4

Biochemical and serological characteristics of natural 9-O-acetyl GD3 from human melanoma and bovine buttermilk and chemically O-acetylated GD3.

Ritter G, Boosfeld E, Markstein E, Yu RK, Ren SL, Stallcup WB, Oettgen HF, Old LJ, Livingston PO. Ritter G, et al. Cancer Res. 1990 Mar 1;50(5):1403-10. Cancer Res. 1990. PMID: 2302705

5

Characterization of IgG and IgM antibodies induced in melanoma patients by immunization with purified GM2 ganglioside.

Livingston PO, Ritter G, Srivastava P, Padavan M, Calves MJ, Oettgen HF, Old LJ. Livingston PO, et al. Among authors: ritter g. Cancer Res. 1989 Dec 15;49(24 Pt 1):7045-50. Cancer Res. 1989. PMID: 2582446

6

Antibody response after immunization with the gangliosides GM1, GM2, GM3, GD2 and GD3 in the mouse.

Livingston PO, Ritter G, Calves MJ. Livingston PO, et al. Among authors: ritter g. Cancer Immunol Immunother. 1989;29(3):179-84. doi: 10.1007/BF00199993. Cancer Immunol Immunother. 1989. PMID: 2731184 Free PMC article.

7

Analysis of the antibody response to immunization with purified O-acetyl GD3 gangliosides in patients with malignant melanoma.

Ritter G, Ritter-Boosfeld E, Adluri R, Calves M, Ren S, Yu RK, Oettgen HF, Old LJ, Livingston PO. Ritter G, et al. Among authors: ritter boosfeld e. Int J Cancer. 1995 Sep 15;62(6):668-72. doi: 10.1002/ijc.2910620604. Int J Cancer. 1995. PMID: 7558412

8

Serological response patterns of melanoma patients immunized with a GM2 ganglioside conjugate vaccine.

Kitamura K, Livingston PO, Fortunato SR, Stockert E, Helling F, Ritter G, Oettgen HF, Old LJ. Kitamura K, et al. Among authors: ritter g. Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2805-9. doi: 10.1073/pnas.92.7.2805. Proc Natl Acad Sci U S A. 1995. PMID: 7708728 Free PMC article.

9

Induction of antibodies reactive with GM2 ganglioside after immunization with lipopolysaccharides from Camplyobacter jejuni.

Ritter G, Fortunato SR, Cohen L, Noguchi Y, Bernard EM, Stockert E, Old LJ. Ritter G, et al. Int J Cancer. 1996 Apr 10;66(2):184-90. doi: 10.1002/(SICI)1097-0215(19960410)66:2<184::AID-IJC8>3.0.CO;2-Z. Int J Cancer. 1996. PMID: 8603809

10

Phase I study of anticolon cancer humanized antibody A33.

Welt S, Ritter G, Williams C Jr, Cohen LS, John M, Jungbluth A, Richards EA, Old LJ, Kemeny NE. Welt S, et al. Among authors: ritter g. Clin Cancer Res. 2003 Apr;9(4):1338-46. Clin Cancer Res. 2003. PMID: 12684402 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

610 results

Search Page

Filters